In Brazil, the early detection of genetic alterations in lung cancer through liquid biopsies could be a valuable tool for ...
More than 70% of people diagnosed with cancer in the United States now survive for five years or more, a milestone experts ...
News Medical on MSN
Liquid Biopsies Boost Lung Cancer Mutation Detection
In Brazil, the early detection of genetic alterations in lung cancer through liquid biopsies could be a valuable tool for ...
First randomized Phase III trial confirming the efficacy of MET inhibition in patients with advanced NSCLC and acquired MET amplification after progression on prior EGFR-TKI treatment - ...
ArriVent BioPharma's furmonertinib demonstrates robust efficacy, CNS penetration, and tolerability in early trials. Read why ...
Firmonertinib has the potential to redefine first-line treatment in this underserved population as a once daily, oral, brain-penetrant, chemo-free monotherapy ALPACCA pivotal trial is designed to ...
Black Diamond Therapeutics Inc. (NASDAQ:BDTX) is one of the best biotech penny stocks to buy according to analysts. On ...
The FDA has granted breakthrough therapy designation (BTD) to sevabertinib (Hyrnuo, formerly BAY 2927088) for the first-line ...
Sevabertinib, targeting HER2 and EGFR mutations, received FDA breakthrough designation for HER2+ NSCLC, showing a 59% overall ...
A research team at the Medical University of Vienna has discovered a new approach to treating a particularly frequent and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback